The global diabetic neuropathy market—focused on managing nerve damage caused by diabetes—is expected to grow from approximately USD 4.34 billion in 2023 to USD 7.28 billion by 2030, registering a CAGR of 7.7%. As the number of diabetes cases escalates worldwide, so does the need for effective neuropathy diagnostics and treatments.
Market Snapshot
2023 Market Size: USD 4.34...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek